Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 18797815 | MHC (MHC) | variola | NA | NA | NA | unclassified | |
| mhc-i-restricted epitopes conserved among variola and other related orthopoxviruses are recognized by t cells 30 years after vaccination. | |||||||
| 12519437 | HLA (HLA) | transfusion-transmitted infections | NA | NA | NA | unclassified | |
| new-generation rbc filters reduce wbc concentrations by 4 to 5 logs and may prevent or decrease transfusion complications such as hla alloimmunization, nonhemolytic febrile reaction, and transfusion-transmitted infections. | |||||||
| 30379846 | HLA-CLASS II (HLA CLASS II) | virus disease | NA | NA | NA | unclassified | |
| amino acid signatures in the hla class ii peptide-binding region associated with protection/susceptibility to the severe west nile virus disease. | |||||||
| 31078470 | HLA-G (HLA-G) | hookworm infection | NA | NA | NA | unclassified | |
| hla-g expression during hookworm infection in pregnant women. | |||||||
| 12621485 | HLA MATCHED (HLA-MATCHED) | cyclophosphamide | NA | fludarabine | NA | unclassified | |
| NA | |||||||
| 27414060 | HLA-A*02 | anaplastic large cell lymphoma | NA | NA | NA | positive | |
| cellular immune responses against the oncoantigen anaplastic lymphoma kinase (alk) in patients with alk-positive anaplastic large cell lymphoma (alcl) have been detected using peptide-based approaches in individuals preselected for human leucocyte antigen (hla)-a*02:01. | |||||||
| 18639006 | HLA-A*11 | acute inflammatory demyelinating polyneuropathy | Chinese | NA | NA | unclassified | |
| association of acute inflammatory demyelinating polyneuropathy with acute lymphoblastic leukaemia and hla-a11. | |||||||
| 22537753 | NA (NA) | autoimmune polyglandular syndrome type ii | NA | NA | NA | unclassified | |
| non-hla autoimmunity genetic factors contributing to autoimmune polyglandular syndrome type ii in tunisian patients. | |||||||
| 12748878 | HLA-DR (HLA-DR) | nstemi | NA | NA | NA | unclassified | |
| we considered t cell subpopulations, t cell surface hla-dr and cd69 expression (evaluated by flow cytometry), lymphomonocyte spontaneous apoptosis (evaluated by elisa), and il2 production (evaluated by elisa) in peripheral blood within 6 hours of onset of nstemi. | |||||||
| 12748878 | HLA-DR (HLA-DR) | nstemi | NA | NA | NA | positive | |
| in nstemi patients we found a significant increase of hladr+ cd3+ and cd69+cd4+ cells. | |||||||
Copyright 2024